153 related articles for article (PubMed ID: 9712049)
21. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1.
Liu C; Lu J; Tan J; Li L; Huang B
Cytokine; 2004 Aug 21-Sep 7; 27(4-5):93-100. PubMed ID: 15271374
[TBL] [Abstract][Full Text] [Related]
22. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes.
Ochrietor JD; Harrison KA; Zahedi K; Mortensen RF
Cytokine; 2000 Jul; 12(7):888-99. PubMed ID: 10880233
[TBL] [Abstract][Full Text] [Related]
23. IL-4 activates a latent DNA-binding factor that binds a shared IFN-gamma and IL-4 response element present in the germ-line gamma 1 Ig promoter.
Berton MT; Linehan LA
J Immunol; 1995 May; 154(9):4513-25. PubMed ID: 7722306
[TBL] [Abstract][Full Text] [Related]
24. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation.
Venkataraman C; Leung S; Salvekar A; Mano H; Schindler U
J Immunol; 1999 Apr; 162(7):4053-61. PubMed ID: 10201928
[TBL] [Abstract][Full Text] [Related]
25. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50.
Delphin S; Stavnezer J
J Exp Med; 1995 Jan; 181(1):181-92. PubMed ID: 7807002
[TBL] [Abstract][Full Text] [Related]
26. The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro.
Cooper C; Johnson D; Roman C; Avitahl N; Tucker P; Calame K
J Immunol; 1992 Nov; 149(10):3225-31. PubMed ID: 1431100
[TBL] [Abstract][Full Text] [Related]
27. Limited expression of C/EBP family proteins during B lymphocyte development. Negative regulator Ig/EBP predominates early and activator NF-IL-6 is induced later.
Cooper CL; Berrier AL; Roman C; Calame KL
J Immunol; 1994 Dec; 153(11):5049-58. PubMed ID: 7963564
[TBL] [Abstract][Full Text] [Related]
28. Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1.
Hu HM; Baer M; Williams SC; Johnson PF; Schwartz RC
J Immunol; 1998 Mar; 160(5):2334-42. PubMed ID: 9498774
[TBL] [Abstract][Full Text] [Related]
29. DNA-binding specificity of PAR and C/EBP leucine zipper proteins: a single amino acid substitution in the C/EBP DNA-binding domain confers PAR-like specificity to C/EBP.
Falvey E; Marcacci L; Schibler U
Biol Chem; 1996 Dec; 377(12):797-809. PubMed ID: 8997490
[TBL] [Abstract][Full Text] [Related]
30. Myb proteins repress human Ig epsilon germline transcription by inhibiting STAT6-dependent promoter activation.
Monticelli S; Ghittoni R; Kabesch M; Vercelli D
Mol Immunol; 2002 Jun; 38(15):1129-38. PubMed ID: 12044779
[TBL] [Abstract][Full Text] [Related]
31. [Role of CAAT/enhancer binding protein in IL-6 regulation of angiotensinogen gene expression].
Zhao Y; Shen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Jun; 15(3):129-32. PubMed ID: 9621116
[TBL] [Abstract][Full Text] [Related]
32. The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer-binding protein-dependent mechanism.
Stütz AM; Pickart LA; Trifilieff A; Baumruker T; Prieschl-Strassmayr E; Woisetschläger M
J Immunol; 2003 Feb; 170(4):1789-96. PubMed ID: 12574343
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte NF-1 and STAT6 cooperate with additional DNA-binding factors to activate transcription of the human polymeric Ig receptor gene in response to IL-4.
Schjerven H; Brandtzaeg P; Johansen FE
J Immunol; 2003 Jun; 170(12):6048-56. PubMed ID: 12794133
[TBL] [Abstract][Full Text] [Related]
34. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
Boruk M; Savory JG; Haché RJ
Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
[TBL] [Abstract][Full Text] [Related]
35. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts.
Hoeck J; Woisetschläger M
J Immunol; 2001 Apr; 166(7):4507-15. PubMed ID: 11254707
[TBL] [Abstract][Full Text] [Related]
36. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production.
Tinnell SB; Jacobs-Helber SM; Sterneck E; Sawyer ST; Conrad DH
Int Immunol; 1998 Oct; 10(10):1529-38. PubMed ID: 9796920
[TBL] [Abstract][Full Text] [Related]
37. Characterization of RNA helicase A as component of STAT6-dependent enhanceosome.
Välineva T; Yang J; Silvennoinen O
Nucleic Acids Res; 2006; 34(14):3938-46. PubMed ID: 16914450
[TBL] [Abstract][Full Text] [Related]
38. Stat6 inhibits human interleukin-4 promoter activity in T cells.
Georas SN; Cumberland JE; Burke TF; Chen R; Schindler U; Casolaro V
Blood; 1998 Dec; 92(12):4529-38. PubMed ID: 9845517
[TBL] [Abstract][Full Text] [Related]
39. c-Rel is a selective activator of a novel IL-4/CD40 responsive element in the human Ig gamma4 germline promoter.
Agresti A; Vercelli D
Mol Immunol; 2002 Mar; 38(11):849-59. PubMed ID: 11922943
[TBL] [Abstract][Full Text] [Related]
40. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300.
Sisk TJ; Gourley T; Roys S; Chang CH
J Immunol; 2000 Sep; 165(5):2511-7. PubMed ID: 10946277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
